DK1137667T3 - GLP-1-analoger - Google Patents

GLP-1-analoger

Info

Publication number: DK1137667T3
Authority: DK; Denmark
Prior art keywords: glp; analogs
Prior art date: 1998-12-07

Application number

DK99963437T

Other languages

English (en)

Inventor

Zheng Xin Dong

Original Assignee

Sod Conseils Rech Applic

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-07

Filing date

1999-12-07

Publication date

2005-02-14

1999-12-07 Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic

1999-12-07 Priority claimed from EP99963437A external-priority patent/EP1137667B1/en

2005-02-14 Application granted granted Critical

2005-02-14 Publication of DK1137667T3 publication Critical patent/DK1137667T3/da

Links

DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Zoology (AREA)
Otolaryngology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Biochemistry (AREA)

DK99963437T 1998-12-07 1999-12-07 GLP-1-analoger DK1137667T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20660198A	1998-12-07	1998-12-07
EP99963437A EP1137667B1 (en)	1998-12-07	1999-12-07	Analogues of glp-1

Publications (1)

Publication Number	Publication Date
DK1137667T3 true DK1137667T3 (da)	2005-02-14

Family

ID=32592693

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99963437T DK1137667T3 (da)	1998-12-07	1999-12-07	GLP-1-analoger

Country Status (7)

Country	Link
EP (1)	EP1359159A3 (da)
CN (1)	CN1935839B (da)
AR (4)	AR021576A1 (da)
CA (1)	CA2778047A1 (da)
DK (1)	DK1137667T3 (da)
PL (1)	PL189664B1 (da)
ZA (2)	ZA200304047B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005203925A1 (en)	2004-01-08	2005-07-21	Theratechnologies Inc.	Glucagon-Like Peptide-1 analogs with long duration of action
CA2733006A1 (en)	2008-08-07	2010-02-11	Ipsen Pharma S.A.S.	Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
KR20110043688A (ko)	2008-08-07	2011-04-27	입센 파마 에스.에이.에스	포도당 의존적인 인슐린 분비 자극성 폴리펩타이드 유사체
WO2014096179A1 (en) *	2012-12-19	2014-06-26	Novo Nordisk A/S	Novel glp-1 receptor agonists with cholesterol efflux activity
AR104932A1 (es) *	2015-06-22	2017-08-23	Lilly Co Eli	Compuestos co-agonistas del glucagón y péptido-1 similar al glugacón (glp-1)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE164852T1 (de) *	1990-01-24	1998-04-15	Douglas I Buckley	Glp-1-analoga verwendbar in der diabetesbehandlung
JP3149958B2 (ja) *	1996-08-30	2001-03-26	ノボノルディスクアクティーゼルスカブ	Ｇｌｐ―１誘導体
UA65549C2 (uk) *	1996-11-05	2004-04-15	Елі Ліллі Енд Компані	Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція

1999
- 1999-12-07 EP EP03076490A patent/EP1359159A3/en not_active Withdrawn
- 1999-12-07 CN CN2006101595556A patent/CN1935839B/zh not_active Expired - Fee Related
- 1999-12-07 ZA ZA200304047A patent/ZA200304047B/xx unknown
- 1999-12-07 PL PL99362031A patent/PL189664B1/pl not_active IP Right Cessation
- 1999-12-07 CA CA2778047A patent/CA2778047A1/en not_active Abandoned
- 1999-12-07 DK DK99963437T patent/DK1137667T3/da active
- 1999-12-07 AR ARP990106236A patent/AR021576A1/es active IP Right Grant
2001
- 2001-05-31 ZA ZA200104478A patent/ZA200104478B/en unknown
2003
- 2003-04-30 AR ARP030101524A patent/AR040228A2/es active IP Right Grant
2007
- 2007-03-29 AR ARP070101341A patent/AR057639A2/es active IP Right Grant
2010
- 2010-06-02 AR ARP100101943A patent/AR076950A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200304047B (en)	2004-04-28
EP1359159A2 (en)	2003-11-05
PL189664B1 (pl)	2005-09-30
CN1935839A (zh)	2007-03-28
CA2778047A1 (en)	2000-06-15
AR040228A2 (es)	2005-03-23
CN1935839B (zh)	2012-06-06
AR076950A2 (es)	2011-07-20
AR021576A1 (es)	2002-07-24
AR057639A2 (es)	2007-12-12
EP1359159A3 (en)	2004-07-21
ZA200104478B (en)	2003-12-01

Publication	Publication Date	Title
DK1070058T3 (da)	2003-08-18	(4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider
FI973772A0 (fi)	1997-09-24	Riktad allmaen saendning i ett radionaet
IS5354A (is)	2000-01-20	Ný efnasambönd
PT860428E (pt)	2005-04-29	Compostos pirimidiona
IS5479A (is)	2000-05-03	Efnasambönd
IS5478A (is)	2000-05-03	Efnasambönd
IS5477A (is)	2000-05-03	Efnasambönd
ID22850A (id)	1999-12-09	Senyawa-senyawa pirazina
NO994877D0 (no)	1999-10-07	Kalsilytiske forbindelser
DE69941708D1 (de)	2010-01-07	Pacap-peptidanaloga
FI973595A0 (fi)	1997-09-03	Telefonsamtals dirigering i ett radiosystem
ID20323A (id)	1998-11-26	Senyawa-senyawa triazinilaminostilbena
EE9900448A (et)	2000-04-17	Ühendid
EP0996458A4 (en)	2001-05-02	SANDRAMYCIN ANALOG
NO20005795D0 (no)	2000-11-16	Antivirale forbindelser
FI973486A0 (fi)	1997-08-25	Datakommunikationsfoerfarande i ett basstationssystem i ett cellulaert radionaet
EE9900475A (et)	2000-06-15	Ühendid
IS5323A (is)	1999-12-28	Efnasambönd
ID22983A (id)	1999-12-23	Senyawa-senyawa fluorometoksimino
PT1076660E (pt)	2002-11-29	(4-bromopirazol-3-il)-benzazolos substituidos
EE9900466A (et)	2000-04-17	Ühendid
DE69737634D1 (de)	2007-05-31	Insektizide oxadiazinverbindungen
FI980629A0 (fi)	1998-03-20	Brandlucka (foer maskinfalsat plaottak)
FI973675A0 (fi)	1997-09-12	Metallkonstruktion foer fixering i ett moensterkort
FI980170A0 (fi)	1998-01-27	Saekerhetsanordning foer bil